References [1]  Pan XF, Wang L, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol 2021; 9: 373–92. [2]  Institute ...

Absci has entered the clinic with its AI-designed antibody, dosing first volunteers in a trial targeting TL1A for ...

Innovent announces phase 3 study of mazdutide in Chinese adults with overweight or obesity (GLORY-1) published in the NEJM: San Francisco, US Tuesday, May 27, 2025, 11:00 Hrs [IST ...

ANI Pharma initiates phase 4 trial of purified Cortrophin Gel to treat acute gout flares: Princeton, New Jersey Friday, May 23, 2025, 14:00 Hrs [IST] ANI Pharmaceuticals, Inc., a ...

Rocket Pharmaceuticals shares plummeted 60% Tuesday after the firm said it halted a study of a gene-therapy drug for Danon ...

Mazdutide is expected to launch in China this year, with anticipated approvals for weight management and glycemic control.

The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

Clinical trials, traditionally plagued by low success rates and high operational costs, are being reengineered through AI ...

In the evolving field of neurodegenerative medicine, the challenge is not merely discovering new treatments but ensuri ...

The poster titled, A Phase Ib Study to Evaluate the Pharmacodynamics, Safety, and Tolerability of the Novel Neuroplastogen DLX-001 in Participants with Major Depressive Disorder: Interim Findings, was ...

In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a ...